Localized skin eruption due to drugs and medicaments taken internally
ICD-10 L27.1 is a billable code used to indicate a diagnosis of localized skin eruption due to drugs and medicaments taken internally.
Localized skin eruption due to drugs and medicaments taken internally, classified under ICD-10 code L27.1, refers to skin reactions that occur as a direct result of systemic medications. Clinically, these eruptions can manifest as erythematous patches, urticaria, or vesicular lesions, often localized to areas where the drug has been metabolized or excreted. The skin, being the largest organ, is particularly sensitive to various pharmacological agents, and reactions can vary widely based on individual patient factors, including genetics, existing skin conditions, and concurrent medications. Disease progression may involve initial mild irritation that can escalate to more severe reactions, such as drug-induced dermatitis or even anaphylaxis in rare cases. Diagnostic considerations include a thorough patient history to identify recent medication use, physical examination of the skin lesions, and potentially, patch testing or biopsy to rule out other dermatological conditions. Accurate diagnosis is critical for effective management and to prevent further exposure to the offending agent.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L27.1 covers localized skin eruptions such as contact dermatitis, drug-induced urticaria, and localized drug reactions. It is essential to establish a clear link between the eruption and the specific medication taken.
L27.1 should be used when the skin eruption is localized and directly linked to a specific medication taken internally, as opposed to generalized eruptions or those caused by topical agents.
Documentation should include a comprehensive medication history, details of the skin eruption (onset, duration, characteristics), and any relevant laboratory or diagnostic tests that support the diagnosis.
